An open-label, multi-center, phase I/II study to assess safety, disease progression, and cellular kinetics following YTB323 administration in participants with non-active Progressive Multiple Sclerosis [PMS] (NCT06675864)
CYTB323R12101
This trial is Currently recruiting
Registration number NCT06675864
Program & service
This trial is being run with the Brain service, and as part of the MSNI program.
Trial phase
Phase 1
Trial participation type
This trial has been designed for the Clinical Research of a Device.
Principal investigator
Associate Professor Mastura Monif
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.